For over 10 years, the Evaux laboratories have been committed to cancer supportive care to ease the side effects of cancer treatments (chemotherapy and radiotherapy) linked to the skin and mucosa. Evaux considers a number of critical effects that affect nails (Evonail), skin (Evoskin), mouth (Evomucy) and intimate parts (Evogyn).
The Evaux products have been clinically tested on cancer patients and the results are positive. The Evonail clinical tests (treatment to prevent and treat damaged nails) was presented to the ASCO in Chicago, the Annual World Congress for the American Society of Clinical Oncology.
No products for this manufacturer.